Literature DB >> 15211104

Five reasons why health care quality research hasn't affected competition law and policy.

David A Hyman1.   

Abstract

Research on health care quality has become increasingly sophisticated, but the research has not had a major impact on competition law and policy. Five specific translational barriers (relevance/litigation dynamics, complexity, framing, judicial and administrative skepticism, and inadequate demand) are identified. If researchers on health care quality want to have an impact on competition law and policy they must confront and overcome these translational barriers.

Mesh:

Year:  2004        PMID: 15211104     DOI: 10.1023/B:IHFE.0000032421.54279.c6

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  3 in total

1.  Antitrust, health care quality, and the courts.

Authors:  Peter J Hammer; William M Sage
Journal:  Columbia Law Rev       Date:  2002-04

2.  Why competition law matters to health care quality.

Authors:  William M Sage; David A Hyman; Warren Greenberg
Journal:  Health Aff (Millwood)       Date:  2003 Mar-Apr       Impact factor: 6.301

3.  The Federal Trade Commission in action: the FTC's Robert F. Leibenluft. Interview by John K. Inglehart.

Authors:  R F Leibenluft
Journal:  Health Aff (Millwood)       Date:  1998 Sep-Oct       Impact factor: 6.301

  3 in total
  1 in total

1.  Quality health care in the European Union thanks to competition law.

Authors:  Diego Fornaciari
Journal:  Int J Environ Res Public Health       Date:  2009-12-24       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.